Uterotonic agents for preventing postpartum haemorrhage: a network meta‐analysis
ID Gallos, A Papadopoulou, R Man… - Cochrane Database …, 2018 - cochranelibrary.com
Background Postpartum haemorrhage (PPH) is the leading cause of maternal mortality
worldwide. Prophylactic uterotonic agents can prevent PPH, and are routinely …
worldwide. Prophylactic uterotonic agents can prevent PPH, and are routinely …
[HTML][HTML] Uterotonic drugs to prevent postpartum haemorrhage: a network meta-analysis.
BACKGROUND Postpartum haemorrhage (PPH) is the leading cause of maternal mortality
worldwide. Prophylactic uterotonic drugs can reduce blood loss and are routinely …
worldwide. Prophylactic uterotonic drugs can reduce blood loss and are routinely …
Efficacy of misoprostol for the treatment of postpartum hemorrhage: current knowledge and implications for health care planning
N Prata, K Weidert - International journal of women's health, 2016 - Taylor & Francis
Background A myriad of interventions exist to treat postpartum hemorrhage (PPH), ranging
from uterotonics and hemostatics to surgical and aortic compression devices. Nonetheless …
from uterotonics and hemostatics to surgical and aortic compression devices. Nonetheless …
[PDF][PDF] Prophylactic misoprostol for the prevention of postpartum hemorrhage: a randomized controlled trial
Y Uncu, M Karahasan, Ö Uyaniklar… - Eur Rev Med …, 2015 - europeanreview.org
OBJECTIVE: Postpartum hemor-rhage (PPH) is one of the major preventable causes of
maternal death in developing countries. Although the non-parenteral use of misoprostol is a …
maternal death in developing countries. Although the non-parenteral use of misoprostol is a …
The efficacy of misoprostol in reducing intraoperative blood loss in women undergoing elective cesarean section. A systematic review and meta‐analysis
Objectives To evaluate the efficacy of misoprostol to minimized blood loss during and after
cesarean delivery (CD). Search Strategy Screening of MEDLINE, EMBASE, Web of Science …
cesarean delivery (CD). Search Strategy Screening of MEDLINE, EMBASE, Web of Science …
Comparison of rectal misoprostol's effect when used before and after a cesarean section on post-cesarean bleeding
A Sharafi, M Ghasemi - Journal of gynecology obstetrics and human …, 2019 - Elsevier
Objective Cesarean section is a common surgery in women. Different drugs are used to
control its bleeding. This study compared the effect of using rectal misoprostol before and …
control its bleeding. This study compared the effect of using rectal misoprostol before and …
Comparison of the effect of intravenous tranexamic acid and sublingual misoprostol on reducing bleeding after cesarean section: A double-blind randomized clinical …
Purpose To evaluate the effects of intravenous tranexamic acid (TA) and sublingual
misoprostol on reducing bleeding after cesarean section. Materials One hundred and fifty …
misoprostol on reducing bleeding after cesarean section. Materials One hundred and fifty …
Comparing and combining evidence of treatment effects in randomized and nonrandomized studies on the use of misoprostol to prevent postpartum hemorrhage
F Morfaw, B Miregwa, A Bi, L Mbuagbaw… - Journal of Evidence …, 2021 - Wiley Online Library
Objective Postpartum hemorrhage (PPH) is a preventable condition and the main cause of
maternal death worldwide. Evidence on the effectiveness of misoprostol in the prevention of …
maternal death worldwide. Evidence on the effectiveness of misoprostol in the prevention of …
Comparison between the effect of sublingual and rectal misoprostol on hemoglobin level change before and after caesarean section
MAE Sayed, SM Sayed… - Egyptian Journal of …, 2020 - ejmr.journals.ekb.eg
Cesarean delivery is the commonest woman surgery worldwide. Postpartum hemorrhage is
blood loss> 1000 ml after SC. This study conducted to assess the efficacy of sublingual …
blood loss> 1000 ml after SC. This study conducted to assess the efficacy of sublingual …
Adjuvant Intravenous Tranexamic Acid Increases the Efficacy of Sublingual Misoprostol Compared with Carbetocin to Reduce the Amount of Blood loss During …
NW Shady, AA Taha, HF Sallam - Journal of Obstetrics, Gynecology and …, 2023 - jogcr.com
Background & Objective: To determine the safety and adequacy of intravenous (IV)
carbetocin compared to IV tranexamic acid (TA) plus sublingual misoprostol in reducing …
carbetocin compared to IV tranexamic acid (TA) plus sublingual misoprostol in reducing …